0920-0740
Medical Monitoring Project (MMP) Summary of Changes to Data Collection Instruments
Changes to 2013 Standard Interview questionnaire:
Changes to the 2013 questionnaire relative to the 2012 questionnaire can also be seen in the document “MMP_2013Interview_v.9.3.11_Redlined.docx.”
Type of change |
Module |
Question # |
Description |
Burden |
Notes |
Deletion |
Preliminary Information |
I3 |
Interview setting not used in national analyses. |
No change |
Preliminary information is completed by interviewer before interview. |
Deletion |
Access to Care |
A10, A10a-A10b, A12, A12a-A12c, A13, A13a-A13o, A14, A14a-A14o, A15b-A15d, A17b-A17h |
Sources of care data no longer needed for data weighting purposes. |
Reduce |
Remove 49 |
Deletion |
Access to Care |
A37a-A37c |
Removed the “other, specify” response for this series of HIV-related services. Data from previous cycles have informed the decision to add 3 services to this series, but other data have not yielded additional useful services, and this option is no longer needed. |
Reduce |
Remove 1 |
Deletion |
Health Conditions and Preventive Therapy |
C5, C5a |
Date and result of first viral load test are unlikely to be reliably reported and are not meaningful analysis variables. |
Reduce |
Remove 2 |
Deletion |
Acculturation |
L2-L6 |
Language acculturation questions were redundant with language use questions that were added based on Office of Minority Health guidance (see below). |
Reduce |
Remove 5 |
Deletion |
Gynecological and Reproductive History |
G3, G3b, G3c, G4, G4a-G4c |
No longer need questions about whether women have been pregnant and given birth post-infection, whether these occurred in past 12 months, and number of pregnancies and births since the new series of questions enumerates dates and outcomes for up to 5 post-infection pregnancies. |
Reduce |
Remove 7 |
Addition |
Preliminary Information |
I1d |
Developed an additional check for participant ID given input errors in previous cycles. |
No change |
Preliminary information is completed by interviewer before interview. |
Addition |
Demographics |
D4a |
Added question on Hispanic origin per guidelines of the Office of Minority Health. |
Increase |
Add 1 |
Addition |
Demographics |
D7, D8, D8a |
Added questions per guidelines of the Office of Minority Health: How well do you speak English? Do you speak a language other than English at home? What is this language? |
Increase |
Add 3 |
Addition |
Demographics |
D17
|
Added BRFSS question about employment status to obtain a richer description of socioeconomic status. |
Increase |
Add 1 |
Addition |
Demographics |
D19b |
Added question about household dependents under age 18 for calculation of poverty measures. |
Increase |
Add 1 |
Addition |
Access to Care |
A9 |
“Do you have a person you think of as your HIV doctor, nurse, or other healthcare provider?” added to enhance understanding of primary care. |
Increase |
Add 1 |
Addition |
Access to Care |
A10a, A10b |
Added satisfaction with care questions to describe patient-provider care. |
Increase |
Add 2 |
Addition |
Access to Care |
A11, A11a |
A11: “What is the name of your usual place of HIV care?” The answer to this question is not recorded. A11a: “Is the respondent’s usual place of care the same as the sampled facility?” is then answered by the interviewer and used for weighting data. |
Increase |
Add 1 |
Addition |
Access to Care |
A15a |
“Was your usual place of general medical care the same as your usual place of HIV medical care?” is used for weighting data. |
Increase |
Add 1 |
Addition |
Met and Unmet Needs |
A37, A38 |
Based on review of the “other, specify” responses for this question from previous cycles, we added vision and legal services to the list of services. |
Increase |
Add 2 |
Addition |
HIV Treatment and Adherence |
T5 |
A new antiretroviral medication (Stribild) was added to the list. |
Increase |
Add 1 |
Addition |
HIV Treatment and Adherence |
T16 |
Added adherence question, recommended by the CDC Prevention branch and aligned with Prevention with Positives guidelines: “During the past 12 months, did your doctor or other clinic staff ask you whether you missed taking any doses of your antiretroviral medicines or had difficulty taking your antiretroviral medicines?” |
Increase |
Add 1 |
Addition |
Drug and Alcohol Use |
U12 |
Ever-use of injection drugs was asked in previous cycles and brought back because it is an important HIV risk factor. |
Increase |
Add 1 |
Addition |
Transmission Risk Behaviors |
B1-B21 |
HIV acquisition behaviors were added to supplement National HIV Surveillance System (NHSS) data. |
Increase |
Add 15 maximum (there are 21 total questions but 2 separate lines which depend on sex/gender combinations of respondents and partners. Not all are asked of all respondents. |
Addition |
Prevention Activities |
P3 |
Added question, recommended by the CDC Prevention branch and aligned with Prevention with Positives guidelines: “During the past 12 months, have you seen or received any informational/educational materials such as posters, leaflets, pamphlets, or videos that tell you how to protect you or your partners from HIV or other STDs?” |
Increase |
Add 1 |
Addition |
Health Conditions and Preventive Therapy |
C1c |
Brought back this question from previous cycles: “What was the result of your lowest CD4 count?” |
Increase |
Add 1 |
Addition |
Health Conditions and Preventive Therapy |
C8, C8a-C8c |
At the request of the MMP Medical Records Abstraction workgroup, added questions about TB testing and results. |
Increase |
Add 4 |
Addition |
Health Conditions and Preventive Therapy |
C14-C19 |
Added 6 disability questions per Office of Minority Health guidelines. |
Increase |
Add 6 |
Addition |
Gynecological and Reproductive History |
G1 |
Brought question back from previous cycles: “During the past 12 months, have you had a pelvic examination?” |
Increase |
Add 1 |
Addition |
Gynecological and Reproductive History |
G3 |
Added question for women only about use of any of 16 contraceptive methods to better understand pregnancy prevention among HIV-infected women: “Have you used this method to prevent pregnancy in the past 12 months?” |
Increase |
Add 1 |
Addition |
Gynecological and Reproductive History |
G5a-d G6a-d G7a-d G8a-d G9a-d |
Added series questions for women only about up to 5 pregnancies after HIV-infection, including pregnancy intention, outcome, date of outcome, and HIV infection of child (if live birth); or pregnancy due date if currently pregnant. |
Increase |
Maximum 20 out of 25 for a woman with 5 pregnancies. Maximum of 8 for a woman with 2 pregnancies (estimated average in this population. |
Addition |
Gynecological and Reproductive History |
G10 |
Brought back from previous cycles: During the past 12 months, have you received HIV care at an OBGYN or gynecological clinic?” |
Increase |
Add 1 |
Modification |
Preliminary Information |
I3 |
Removed reference to handheld devices since they are discontinued in 2013. |
No change |
No change (preliminary information is completed by interviewer before interview). |
Modification |
Demographics |
D2 |
Omitting day of birth for data confidentiality. |
No change |
No change |
Modification |
Demographics |
D4 |
Added “or Spanish origin” to comply with Office of Minority Health guidelines: “Do you consider yourself to be of Hispanic or, Latino/a or Spanish origin?” |
No change |
No change |
Modification |
Demographics |
D11 |
Removed “other” option from question about sexual orientation based on lack of useable data from previous cycles. |
No change |
No change |
Modification |
Demographics |
D15h |
Added “city, county, state of other publicly funded insurance” to list of health insurance types to minimize recoding of “other” category. |
No change |
No change |
Modification |
Demographics |
D19 |
Changed income categories to have finer gradation among lower incomes. |
No change |
No change |
Modification |
Gynecological and Reproductive History |
G2 |
Removed the second “other, specify” option from this question about where respondent went for testing, diagnosis, or treatment of a sexually transmitted disease. One “other” option is adequate based on review of data from previous cycles. |
No change |
No change |
Modification |
Gynecological and Reproductive History |
G12 |
Returned to exact wording of question from 2009 cycle (removed “vaginal or cervical”: “During the past 12 months, have you had a Pap smear?” |
No change |
No change |
Changes to Medical Record Abstraction (MRA)
MMP medical record abstraction will continue to be conducted by MMP staff and thus will not contribute to the overall burden of the project. The previously approved MRA forms will be consolidated into one web-based form and abstraction will be focused on the prior two years of care. The attachment “MRA 2013 Screenshots ” contains the data elements for 2013. Information that is not reliably recorded in medical records will no longer be abstracted. Changes relative to 2012 are summarized below:
Data elements present in MRA 2012 but absent in MRA 2013
Sex at birth
Country of birth
AIDS defining opportunistic illnesses which occurred prior to the surveillance period start date
Antiretroviral therapy administered prior to the surveillance period start date
HIV viral load results prior to the surveillance period start date
HIV ART resistance testing results prior to the surveillance period start date
Documentation of PCP prophylaxis prior to the surveillance period start date
Documentation of MAC prophylaxis prior to the surveillance period start date
Hepatitis A, B, and C screening results prior to the surveillance period start date
Toxoplasma screening results prior to the surveillance period start date
Tuberculosis screening results prior to the surveillance period start date
Documentation of Hepatitis A or B vaccination prior to the surveillance period start date
Documentation of Pneumococcal vaccination prior to the surveillance period start date
Documentation of alcohol abuse prior to the surveillance period start date
Documentation of non-prescribed substance abuse prior to the surveillance period start date
Mental health illness diagnoses prior to the surveillance period start date
Country of residence during the surveillance period
Services provided during the surveillance period including: case management, chemotherapy, education session, hospice care, nursing home care, nutrition counseling, physical therapy, prenatal care, receipt of equipment or supplies, support group, substance abuse counseling or treatment, pharmacist consultation
Documentation of Hepatitis A or B vaccination during the surveillance period
Documentation of Pneumococcal vaccination during the surveillance period
Referrals made during the surveillance period including: adherence support, case manager services, dental care, financial assistance, food and housing support, HIV prevention counseling, home-based care, intimate partner violence services, mental health services, partner counseling and referral, reproductive health, social work services, substance abuse prevention, TB treatment services
Documentation of alcohol abuse during the surveillance period
Documentation of non-prescribed substance abuse during the surveillance period
AIDS defining opportunistic illnesses occurring during hospitalizations in the surveillance period
Other medical conditions occurring during hospitalizations during the surveillance period
Antiretroviral therapy prescribed during hospitalizations during the surveillance period
Other medications prescribed during hospitalizations during the surveillance period
Laboratory results obtained during hospitalizations during the surveillance period
Laboratory Test Results during the surveillance period:
Urinary HCG results
Anti-HAV IgG, IgM, Anti-HAV Total
Anti-HBc IgM, Anti-HBc Total, HBeAg
HCV genotype
HPV DNA PCR
Resistance test for INH
Resistance test for Rifampin
Phenotypic ART resistance test results
Data elements present in MRA 2013 but absent in MRA 2012
Source of lowest CD4 count data
HIV provider encounters during the data collection period:
Where did the encounter take place?
With whom did the encounter take place?
Did the encounter take place with a known HIV provider?
Were any vital signs documented during the encounter
Was ≥ 1 physical exam findings documented during the encounter
Was antiretroviral therapy prescribed or refilled during the encounter
Non-HIV provider encounters during the data collection period
Did encounter take place with a non-HIV provider?
If yes, specify provider type
Physical exam findings during each visit: height, weight, systolic/ diastolic blood pressure
Select procedures received during the data collection period
Mammogram date and results during the surveillance period
Laboratory results:
HIV resistance tropism assay results
HIV resistance mutation results from genotype and virtual phenotypes
Serum calcium
Intact PTH
Vitamin D3, 25-hydroxy [25(OH)D3]
Total Testosterone
INR
TSH
CBC with differential
Urine albumin, urine creatinine
Changes to Minimum Dataset (MDS):
MMP minimum data set collection will continue to be conducted by MMP staff through an electronic extract of existing NHSS data and thus does not contribute to the overall burden of the project. Based on recommendations from NHSS staff, we propose adding 34 data elements to this extract in order to increase the completeness and quality of MDS data. Some added data elements are needed to ensure that calculated variables already approved for collection from NHSS can be disaggregated accurately (e.g. breakdowns of HIV acquisition risk information). Other data elements added will be used as data quality indicators (e.g., date record entered in NHSS, quality flag entered by local NHSS staff). New data elements proposed for 2013 are appear at the bottom of the table in highlighted, bold font starting with number 253 and ending with 505 (though not consecutively numbered).
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Linda Beer |
File Modified | 0000-00-00 |
File Created | 2021-01-29 |